Harm and risk reduction: History, theories, issues, and implications

Substance Use and Misuse

Volumn 42, Issue 2-3, 2007, Pages 257-265

  Einstein, S ^a,b  

^a Middle Eastern Summer Institute on Drug Use   (Israel)

^b MESIDU   (Israel)

Author keywords

"normed"; Care sites; Harm production; Harm reduction; Marginalized; Stakeholders

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; METHADONE; MORPHINE; NALOXONE; NEUROLEPTIC AGENT; OPIATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DRUG DEPENDENCE; HARM REDUCTION; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IDEOLOGY; LIFE CYCLE; NONHUMAN; PATHOLOGY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOSIS; RISK REDUCTION; SELF CARE; SEXUALLY TRANSMITTED DISEASE; SOCIAL CONTROL; SOCIAL WORK; VACCINATION;

ETHICAL THEORY; HARM REDUCTION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; ISRAEL; PREJUDICE; PUBLIC POLICY; SUBSTANCE-RELATED DISORDERS;

EID: 34250204194     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080601141990     Document Type: Article

References (22)

1. Brandt, A. M., Rozin, P. (1997). Morality and health. New York: Routledge.
2. Conklin, J. Wicked problems and fragmentation. In Dialog mapping: Making sense of project fragmentation; Ch 2, (Unpublished manuscript).
3. Erickson, P. G., Riley, D., Cheung, Y.W., O'Hare, P. (Eds.). (1997). Harm reduction: A new direction for drug policies and programs. Toronto: University of Toronto Press.
4. Goffman, E. (1952). On cooling the mark out: Some aspects of adaptation to failure. Psychiatry 15:451-463.
5. Goffman, E. (1968). Stigma. Notes on the management of spoiled identity. Pelican Books.
6. Heschel, A. J. (1959). The patient as a person. In The insecurity of freedom: Essays on human existence (pp. 24-39). New York: Schocken Books.
7. Hill, J., Cheadle, R. (1996). The Bible tells me so: Uses and abuses of holy scripture. New York: Anchor Books/Doubleday.
8. Kleinig, J. (Ed.). (2004). Ethical issues of substance use intervention. Substance Use & Misuse 40:3.
9. Inciardi, J. A., Harrison, L. D. (Eds.). (2000). Harm reduction: National and international perspectives. Beverly Hills: CA: Sage Publications.
10. Kahneman, D., et al. Judgment under uncertainty: Heuristics and biases. London: Cambridge University Press.
11. Kleinig, J. (2006). Thinking ethically about needle and syringe programs. In J. Kleinig, S. Einstein (Eds.), Ethical challenges for intervening in drug use. Huntsville, TX.
12. Kropotkin, P. A. (1921). Mutual aid: A factor of evolution. New York: New York University Press.
13. MacCoun, R. J., Reuter, P. (2001). Drug war heresies: Learning from other vices, times and places. London: Cambridge University Press.
14. Moynihan, R., Henry, D. (2006). The fight against disease mongering: Generating Knowledge for action. PLeS Med 3(4): 191.
15. Porter, R., Teich, M. (Eds.). (1995). Drugs and narcotics in history. Cambridge: Cambridge University Press.
16. Richard, T. (1970). The gift relationship: From human blood to social policy. London: Allen&Unwin.
17. Sieber, S. D. ( 1981). Fatal remedies. New York: Plenum.
18. Terry, C. E., Pellens, M. (1928). The opium problem. New York: Bureau of Social Hygiene.
19. Von Foerster, H., Mora, P. M., Amiot, L. W. (1960). Doomsday: Friday, 13 November, A.D., 2026. Science 132:1291-1295.
20. Vuchinich, R. E., Heather, N. (Eds.). (2003). Choice, behavioral economics and addiction. New York: Pergamon.
21. World Health Organization. (1948). Off. Rec. Hlth. Org., 2(100).
22. Younge, S. L., Oetting, E. R., Banning, J. H., Younge, K. A. (1990). Psychological messages from the physical environment: The drug and alcohol treatment center environment. The International Journal of the Addictions 25(7A-8A):905-955.